Evidence map›Paper›PMID 31888322›Full record

ArticleThe Korean journal of pain2020

Dexmedetomidine during suprazygomatic maxillary nerve block for pediatric cleft palate repair, randomized double-blind controlled study.

Mohamed F Mostafa, Fatma A Abdel Aal, Ibrahim Hassan Ali, Ahmed K Ibrahim, Ragaa Herdan

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in The Korean journal of pain, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06100315 (Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair), which is not on this map. Cited by 7 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 4 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06100315 active not recruitingnot on this mapstarted 2023, after this paper: background citation

Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair: A Prospective, Randomized Comparative, Controlled Double-blind Study.

TypeobservationalSponsorAssiut UniversityRan2023 to 2026Enrolled60ConditionsComplication Following Peripheral Nerve BlockArmsNalbuphine
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mohamed F MostafaDepartment of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID http://orcid.org/0000-0002-3500-7339
Fatma A Abdel AalDepartment of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID http://orcid.org/0000-0002-6964-0319
Ibrahim Hassan AliDepartment of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID http://orcid.org/0000-0002-8378-6103
Ahmed K IbrahimDepartment of Public Health, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID http://orcid.org/0000-0001-7038-217X
Ragaa HerdanDepartment of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID http://orcid.org/0000-0001-9782-5284
Assiut University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor children with cleft palates, surgeries at a young age are necessary to reduce feeding or phonation difficulties and reduce complications, especially respiratory tract infections and frequent sinusitis. We hypothesized that dexmedetomidine might prolong the postoperative analgesic duration when added to bupivacaine during nerve blocks.

methodsEighty patients of 1-5 years old were arbitrarily assigned to two equal groups (forty patients each) to receive bilateral suprazygomatic maxillary nerve blocks. Group A received bilateral 0.2 mL/kg bupivacaine (0.125%; maximum volume 4 mL/side). Group B received bilateral 0.2 mL/kg bupivacaine (0.125%) + 0.5 µg/kg dexmedetomidine (maximum volume 4 mL/side).

resultsThe modified children's hospital of Eastern Ontario pain scale score was significantly lower in group B children after 8 hours of follow-up postoperatively (

conclusionsAddition of dexmedetomidine 0.5 µg/kg to bupivacaine 0.125% has accentuated the analgesic efficacy of bilateral suprazygomatic maxillary nerve block in children undergoing primary cleft palate repair with less postoperative supplemental analgesia or untoward effects.

Indexed as

AnalgesiaBupivacaineChildCleft PalateDexmedetomidineMaxillary NerveNerve BlockPainPostoperative

Identifiers

PMID31888322
PMCPMC6944365
OpenAlexW2996916703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.